Mar 4, 2019 07:40AM

Mar 4, 2019 07:30AM

Feb 22, 2019 05:15PM

Feb 4, 2019 05:02PM

Feb 4, 2019 05:00PM

Nov 26, 2018 03:54PM

Nov 21, 2018 04:22PM Intellipharmaceutics (IPCI) Announces Exclusive Supply Agreement for Abuse-Deterrent Oxycodone ER Product Candidate & Four Generic Drug Products in Philippines

Nov 21, 2018 04:20PM

Nov 20, 2018 05:35PM

Oct 16, 2018 07:05PM

Oct 15, 2018 05:15PM

Oct 12, 2018 06:21AM

Oct 12, 2018 06:15AM

Oct 10, 2018 10:20PM Intellipharmaceutics Announces Completion of the Clinical Component of Category 2 and 3 Human Abuse Liability Studies for Oxycodone ER

Oct 1, 2018 08:00AM

Sep 11, 2018 07:15AM

Jul 16, 2018 05:00PM

Jun 8, 2018 05:20PM

May 16, 2018 08:00AM

May 8, 2018 08:00AM

Apr 27, 2018 08:00AM Intellipharmaceutics Files Appeal to Nasdaq Delisting Determination

Apr 23, 2018 05:02PM

Apr 23, 2018 05:00PM

Apr 16, 2018 05:00PM

Apr 16, 2018 05:00PM

Mar 21, 2018 04:30PM

Mar 19, 2018 02:57PM

Mar 19, 2018 02:55PM Intellipharmaceutics Announces US$1.8 Million Registered Direct Offering

Mar 16, 2018 07:45PM

Mar 14, 2018 09:04AM

Mar 14, 2018 09:00AM

Feb 16, 2018 06:00AM

Feb 9, 2018 08:06AM

Feb 9, 2018 08:00AM

Jan 24, 2018 08:25AM Intellipharmaceutics (IPCI) Announces Operational Update

Jan 24, 2018 08:00AM

Dec 5, 2017 08:10AM

Dec 5, 2017 08:00AM

Nov 30, 2017 10:45AM

Oct 13, 2017 05:45PM

Oct 11, 2017 08:05AM

Oct 11, 2017 08:00AM Intellipharmaceutics Announces US$4 Million Registered Direct Offering

Oct 10, 2017 05:20PM

Sep 25, 2017 07:01AM

Sep 25, 2017 07:00AM

Sep 20, 2017 05:11PM

Sep 20, 2017 05:10PM

Sep 5, 2017 02:35PM

Sep 1, 2017 08:03AM Intellipharmaceutics (IPCI) Names Andrew Patient as CFO

Sep 1, 2017 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All